Biotechs Under a Buck

[joe_techi]

There are many links out there concerning Nuvilex (NVLX) but this recent one describes the two activities of immediate interest: The Phase 2b trial for pancreatic cancer treatment and also a preclinical study for the symptoms associated with pancreatic cancer (that is imminent or has already started with Von Hoff at TD2)
http://online.wsj.com/article/PR-CO-20140714-905001.html

This is just a good site to get an overall broad brush feel for Nuvilex activities
http://www.stockmarketmediagroup.com/features/nvlx/

I think NVLX is quite a hidden gem with a lot of catalysts on several fronts. I anticipate high probability of great news and subsequent stock price appreciation in the very near term, IMO end of this calendar year and then first half of 2015 for news on the Phase 2b and the preclinical above. Good luck.